Global Pharmacovigilance and Drug Safety Software Market – Industry Analysis and Forecast (2017-2024) _ by Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand/Cloud Based), by End User and by Geography

Market Scenario

Global Pharmacovigilance and Drug Safety Software Market is expected to reach USD 210.90 Million by 2024 from USD 138.26 Million in 2016 at CAGR of 5.42% (Detailed analysis of the market CAGR is provided in the report Global Pharmacovigilance and Drug Safety Software Market Drug Safety Software assist organizations to review, classify, create and other pharmacovigilance data is termed as PV software (or Pharmacovigilance software). This software also assist in creation of adverse event reports. Global Pharmacovigilance and Drug Safety Software Market is segmented by functionality, delivery mode, end user, and geography. Functionality segment is classified as adverse event reporting software, drug safety audits software, issue tracking software and fully integrated software. Delivery mode segment is bifurcated as on-premises and on-demand/cloud based. On-demand/cloud based Delivery mode segment is expected to register highest growth during forecast period. Rise in demand for self-driven analytics, lack of upfront capital investments for hardware, extreme capacity flexibility will fuel the on-demand/cloud based Delivery mode segment growth. End user segment is divided as pharma and biotech companies, contract research organizations (CROS), business process outsourcing (BPO) firms and other pharmacovigilance service providers. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. Rising pressure on pharma and biotech makes to produce safe drugs and increasing adoption of related software services by numerous outsourcing firms are trending the overall Global Pharmacovigilance and Drug Safety Software Market. APAC is going to emerge as highest growth region in Pharmacovigilance and Drug Safety Software Market in forecast period followed by North America and Europe. Rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging economies like India and China will fuel the Pharmacovigilance and Drug Safety Software Market in APAC region. Key Highlights: • Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Pharmacovigilance and Drug Safety Software Market analysis and comprehensive segmentation with respect to the functionality, delivery mode, end user, and geography to assist in strategic business planning • Global Pharmacovigilance and Drug Safety Software Market analysis and forecast for five major geographies North America, Europe, Asia pacific, Middle East & Africa, Latin America and their key regions Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get unbiased idea of the market. This exercise was done at country level to get fair idea of the market in countries considered for this study. Later this country specific data was accumulated to come up with regional numbers and then arrive at global market value for Global Pharmacovigilance and Drug Safety Software Market. Global Pharmacovigilance and Drug Safety Software Market Key Players in the Global Pharmacovigilance and Drug Safety Software Market Are: • Umbra Global • United Biosource Corporation • Sparta Systems, Inc • Sarjen Systems Pvt. Ltd • Oracle Corporation. • Online Business Applications, Inc • Ennov • Extedo GMBH. • Arisglobal • AB-Cube Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Pharmacovigilance and Drug Safety Software providers • Contract research organizations (CROs) • Government Bodies Scope of the Report: Research report categorizes the Global Pharmacovigilance and Drug Safety Software Market based on functionality, Delivery mode, end user, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Pharmacovigilance and Drug Safety Software Market with key developments in companies and market trends. Global Pharmacovigilance and Drug Safety Software Market, By Functionality: • Adverse Event Reporting Software • Drug Safety Audits Software • Issue Tracking Software • Fully Integrated Software Global Pharmacovigilance and Drug Safety Software Market, By Delivery Model: • On-Premises • On-Demand/Cloud Based Global Pharmacovigilance and Drug Safety Software Market, By End-User: • Pharma and Biotech Companies • Contract Research Organizations (CROS) • Business Process Outsourcing (BPO) Firms • Other Pharmacovigilance Service Providers Global Pharmacovigilance and Drug Safety Software Market, By Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.   Global Ambulatory Surgery Centers Market - Industry Analysis and Forecast 2024

Table of Contents

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY FUNCTANILITY (2017-2024) 5.1. Introduction 5.2. Adverse Event Reporting Software 5.2.1. Adverse Event Reporting Software Market Overview 5.2.2. Adverse Event Reporting Software Market Size & Forecast 5.3. Drug Safety Audits Software 5.3.1. Drug Safety Audits Software Market Overview 5.3.2. Drug Safety Audits Software Market Size & Forecast 5.4. Issue Tracking Software 5.4.1. Issue Tracking Software Market Overview 5.4.2. Issue Tracking Software Market Size & Forecast 5.5. Fully Integrated Software 5.5.1. Fully Integrated Software Market Overview 5.5.2. Fully Integrated Software Market Size & Forecast 6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY DELIVERY MODEL (2017-2024) 6.1. Introduction 6.2. On-Premises 6.2.1. On-Premises Market Overview 6.2.2. On-Premises Market Size & Forecast 6.3. On-Demand/Cloud Based 6.3.1. On-Demand/Cloud Based Market Overview 6.3.2. On-Demand/Cloud Based Market Size & Forecast 7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END-USER (2017-2024) 7.1. Introduction 7.2. Pharma and Biotech Companies 7.2.1. Pharma and Biotech Companies Market Overview 7.2.2. Pharma and Biotech Companies Market Size & Forecast 7.3. Contract Research Organizations (CROS) 7.3.1. Contract Research Organizations (CROS) Market Overview 7.3.2. Contract Research Organizations (CROS) Market Size & Forecast 7.4. Business Process Outsourcing (BPO) Firms 7.4.1. Business Process Outsourcing (BPO) Firms Market Overview 7.4.2. Business Process Outsourcing (BPO) Firms Market Size & Forecast 7.5. Other Pharmacovigilance Service Providers 7.5.1. Other Pharmacovigilance Service Providers Market Overview 7.5.2. Other Pharmacovigilance Service Providers Market Size & Forecast 8. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY GEOGRAPHY (2017-2024) 8.1. North America Pharmacovigilance and Drug Safety Software Market 8.1.1. North America Pharmacovigilance and Drug Safety Software Market, By Functionality 8.1.2. North America Pharmacovigilance and Drug Safety Software Market, By Delivery Model 8.1.3. North America Pharmacovigilance and Drug Safety Software Market, By End User 8.1.4. North America Pharmacovigilance and Drug Safety Software Market, by Region 8.1.4.1. U.S. Pharmacovigilance and Drug Safety Software Market 8.1.4.2. Canada Pharmacovigilance and Drug Safety Software Market 8.1.4.3. Mexico Pharmacovigilance and Drug Safety Software Market 8.2. Europe Pharmacovigilance and Drug Safety Software Market 8.2.1. Europe Pharmacovigilance and Drug Safety Software Market, By Functionality 8.2.2. Europe Pharmacovigilance and Drug Safety Software Market, By Delivery Model 8.2.3. Europe Pharmacovigilance and Drug Safety Software Market, By End User 8.2.4. Europe Global Pharmacovigilance and Drug Safety Software Market, by Region 8.2.4.1. France Pharmacovigilance and Drug Safety Software Market 8.2.4.2. Germany Pharmacovigilance and Drug Safety Software Market 8.2.4.3. U.K. Pharmacovigilance and Drug Safety Software Market 8.2.4.4. Italy Pharmacovigilance and Drug Safety Software Market 8.2.4.5. Spain Pharmacovigilance and Drug Safety Software Market 8.2.4.6. Rest of Europe Pharmacovigilance and Drug Safety Software Market 8.3. Asia Pacific Pharmacovigilance and Drug Safety Software Market 8.3.1. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, By Functionality 8.3.2. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, By Delivery Model 8.3.3. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, By End User 8.3.4. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, by Region 8.3.4.1. China Pharmacovigilance and Drug Safety Software Market 8.3.4.2. Japan Pharmacovigilance and Drug Safety Software Market 8.3.4.3. India Pharmacovigilance and Drug Safety Software Market 8.3.4.4. South Korea Pharmacovigilance and Drug Safety Software Market 8.3.4.5. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market 8.4. Middle East & Africa Pharmacovigilance and Drug Safety Software Market 8.4.1. Middle East & Africa Pharmacovigilance and Drug Safety Software Market, By Functionality 8.4.2. Middle East & Africa Pharmacovigilance and Drug Safety Software Market, By Delivery Model 8.4.3. Middle East & Africa Pharmacovigilance and Drug Safety Software Market, By End User 8.4.4. Middle East & Africa Pharmacovigilance and Drug Safety Software Market, by Region 8.4.4.1. South Africa Pharmacovigilance and Drug Safety Software Market 8.4.4.2. Rest of Middle East and Africa Pharmacovigilance and Drug Safety Software Market 8.5. Latin America Pharmacovigilance and Drug Safety Software Market 8.5.1. Latin America Pharmacovigilance and Drug Safety Software Market, By Functionality 8.5.2. Latin America Pharmacovigilance and Drug Safety Software Market, By Delivery Model 8.5.3. Latin America Pharmacovigilance and Drug Safety Software Market, By End User 8.5.4. Latin America Pharmacovigilance and Drug Safety Software Market, by Region 8.5.4.1. Brazil Pharmacovigilance and Drug Safety Software Market 8.5.4.2. Rest of Latin America Pharmacovigilance and Drug Safety Software Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Umbra Global 9.3.1.1 Overview 9.3.1.2 Products/ End-User 9.3.1.3 Strategy 9.3.1.4 Key Developments 9.3.2 United Biosource Corporation 9.3.2.1 Overview 9.3.2.2 Products/ End-User 9.3.2.3 Strategy 9.3.2.4 Key Developments 9.3.3 Sparta Systems, Inc 9.3.3.1 Overview 9.3.3.2 Products/ End-User 9.3.3.3 Strategy 9.3.3.4 Key Developments 9.3.4 Sarjen Systems Pvt. Ltd 9.3.4.1 Overview 9.3.4.2 Products/ End-User 9.3.4.3 Strategy 9.3.4.4 Key Developments 9.3.5 Oracle Corporation. 9.3.5.1 Overview 9.3.5.2 Products/ End-User 9.3.5.3 Strategy 9.3.5.4 Key Developments 9.3.6 Online Business Applications, Inc 9.3.6.1 Overview 9.3.6.2 Products/ End-User 9.3.6.3 Strategy 9.3.6.4 Key Developments 9.3.7 Ennov 9.3.7.1 Overview 9.3.7.2 Products/ End-User 9.3.7.3 Strategy 9.3.7.4 Key Development 9.3.8 Extedo GMBH. 9.3.8.1 Overview 9.3.8.2 Products/ End-User 9.3.8.3 Strategy 9.3.8.4 Key Development 9.3.9 Arisglobal 9.3.9.1 Overview 9.3.9.2 Products/ End-User 9.3.9.3 Strategy 9.3.9.4 Key Development 9.3.10 AB-Cube 9.3.10.1 Overview 9.3.10.2 Products/ End-User 9.3.10.3 Strategy 9.3.10.4 Key Development

Inquiry Before Buying

Request Sample

About This Report

Report ID 6345
Category Global Information Technology Telecommunication
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now